Introduction

The EZER^TM TB MPT64 antigen rapid test device is an immunochromatographic assay (ICA) using anti-MPT64 monoclonal antibodies for directly qualitative detection of Mycobacterium tuberculosis complex (MTBC) antigen.

Tuberculosis (TB) is a chronic disease caused by infection with Mycobacterium tuberculosis, mostly affects adults in their most productive years. However, all age groups are at risk. Over 95% of cases and deaths are in developing countries. TB is spread from person to person through the air. When people with lung TB cough, sneeze or spit, they propel the TB germs into the air. A person needs to inhale only a few of these germs to become infected.

About one-quarter of the world’s population has a TB infection, which means people have been infected by TB bacteria but are not (yet) ill with the disease and cannot transmit it.

The number of new TB cases and deaths from TB is estimated at around 10.0 million (2017) and 1.6 million (2017) respectively. 

Features & Benefits

This methodology is intended to detect MPT64 protein secreted from M. tuberculosis complex (M. tuberculosis, M. bovis, M. africanum and M. microti) while culturing and however non-tuberculosis mycobacterium (NTM) produces no MPT64.

● Rapid differentiate M.tuberculosis complex from NTM.

● Both liquid and solid media can be applied as samples.

● One step, fast result, result in 15 minutes.

Detection

The qualitative detection of Mycobacterium tuberculosis complex (MTBC) antigen.

Specimen

Liquid Cultures and Solid Cultures.

Limit of Detection (LoD)

The minimum detection limit is 1.2 x 10⁶CFU/mL.

Accuracy

Sensitivity 99.2%, Specificity 100%

Time to results

Read results at 15minutes and no more than 60 minutes.

Kit storage conditions

2~30°C. 

Ordering Information